RE: "Could Scancell’s Melanoma Trial Results Signal a New Chapter in Biotech Immunotherapy?"22 Jul 2025 14:17
Kalkinemedia.com
Could Scancell’s Melanoma Trial Results Signal a New Chapter in Biotech Immunotherapy?
4–5 minutes
Highlights,Scancell reports Phase II data from Modi-1 trial in melanoma using peptide vaccine with checkpoint inhibitors.,Disease control and immune response observed across multiple patient groups.,Combination treatment with checkpoint inhibitors well to...
'Scancell reports Phase II data from Modi-1 trial in melanoma'.??............I'm not sure about that.